Advertisement

Efficacy of superficial temporal artery-middle cerebral artery double bypass in patients with hemorrhagic moyamoya disease: surgical effects for operated hemispheric sides

  • Taichi Ishiguro
  • Yoshikazu Okada
  • Tatsuya Ishikawa
  • Koji Yamaguchi
  • Akitsugu Kawashima
  • Takakazu KawamataEmail author
ORIGINAL ARTICLE

Abstract

The effects of superficial temporal artery to middle cerebral artery (STA-MCA) double bypass on recurrent hemorrhage in the operated hemisphere in hemorrhagic moyamoya disease (HMD) have not been clearly demonstrated. This study evaluated the effectiveness of STA-MCA double bypass in the prevention of further hemorrhagic or ischemic events in the operated hemispheric sides in comparison to the conservatively treated non-operated sides. We retrospectively analyzed 52 hemispheres of 36 patients with adult-onset HMD treated with STA-MCA double bypass. Twenty and 16 patients underwent unilateral (unilateral group) and bilateral (bilateral group) surgery, respectively. In addition, the perioperative and long-term outcomes of the 52 operated sides and 20 non-operated sides in the unilateral group were compared. All bypass surgeries were successful, but 21% of the operated sides showed hyperperfusion as estimated by our methods. Perioperative mortality and morbidity rate were 0% and 5.6%, respectively. Concerning long-term follow-up, the annual rebleeding rate (ARR) in the unilateral and bilateral group was 2.7% and 2.6%/person-year, respectively (p = 0.256). The ARR in the operated and non-operated sides was 1.1% and 1.8%/side-year, respectively (p = 0.163). Two of 20 non-operated sides suffered from ischemic infarction during the follow-up period, while none of the 52 operated sides experienced ischemic events (p < 0.05). Although the long-term rebleeding rate in the operated hemisphere tended to be lower after STA-MCA double bypass compared with that in the non-operated hemisphere, the difference was not statistically significant. In conclusion, while STA-MCA double bypass could not clearly prevent rebleeding, it can prevent further ischemic attacks in patients with HMD.

Keywords

Hemorrhagic moyamoya disease Middle cerebral artery Superficial temporal artery Double bypass Rebleeding 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

For this type of study, formal consent is not required.

References

  1. 1.
    Choi WS, Lee SB, Kim DS, Huh PW, Yoo DS, Lee TG, Cho KS (2013) Thirteen-year experience of 44 patients with adult hemorrhagic moyamoya disease from a single institution: clinical analysis by management modality. J Cerebrovasc Endovasc Neurosurg 15:191–199.  https://doi.org/10.7461/jcen.2013.15.3.191 CrossRefGoogle Scholar
  2. 2.
    Fujii K, Ikezaki K, Irikura K, Miyasaka Y, Fukui M (1997) The efficacy of bypass surgery for the patients with hemorrhagic moyamoya disease. Clin Neurol Neurosurg 99(Suppl 2):S194–S195CrossRefGoogle Scholar
  3. 3.
    Fujimura M, Shimizu H, Mugikura S, Tominaga T (2009) Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol 71:223–227; discussion 227.  https://doi.org/10.1016/j.surneu.2007.07.077 CrossRefGoogle Scholar
  4. 4.
    Funaki T, Takahashi JC, Yoshida K, Takagi Y, Fushimi Y, Kikuchi T, Mineharu Y, Okada T, Morimoto T, Miyamoto S (2016) Periventricular anastomosis in moyamoya disease: detecting fragile collateral vessels with MR angiography. J Neurosurg 124:1766–1772.  https://doi.org/10.3171/2015.6.jns15845 CrossRefGoogle Scholar
  5. 5.
    Houkin K, Kamiyama H, Abe H, Takahashi A, Kuroda S (1996) Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage? Stroke 27:1342–1346CrossRefGoogle Scholar
  6. 6.
    Huang Z, Ding X, Men W, Zhang D, Zhao Y, Wang R, Wang S, Zhao J (2015) Clinical features and outcomes in 154 patients with haemorrhagic moyamoya disease: comparison of conservative treatment and surgical revascularization. Neurol Res 37:886–892.  https://doi.org/10.1179/1743132815y.0000000073 CrossRefGoogle Scholar
  7. 7.
    Iwama T, Kotani Y, Yamakawa H, Nagata I, Hashimoto N, Sakai N (2001) Cerebral ischemic complications following intracranial bleeding in patients with moyamoya disease—three case reports. Neurol Med Chir 41:450–453CrossRefGoogle Scholar
  8. 8.
    Jiang H, Ni W, Xu B, Lei Y, Tian Y, Xu F, Gu Y, Mao Y (2014) Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass. J Neurosurg 121:1048–1055.  https://doi.org/10.3171/2014.7.jns132434 CrossRefGoogle Scholar
  9. 9.
    Kang CK, Park CW, Han JY, Kim SH, Park CA, Kim KN, Hong SM, Kim YB, Lee KH, Cho ZH (2009) Imaging and analysis of lenticulostriate arteries using 7.0-Tesla magnetic resonance angiography. Magn Reson Med 61:136–144.  https://doi.org/10.1002/mrm.21786 CrossRefGoogle Scholar
  10. 10.
    Kawaguchi S, Okuno S, Sakaki T (2000) Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg 93:397–401.  https://doi.org/10.3171/jns.2000.93.3.0397 CrossRefGoogle Scholar
  11. 11.
    Kawamata T, Okada Y, Kawashima A, Yoneyama T, Yamaguchi K, Ono Y, Hori T (2009) Postcarotid endarterectomy cerebral hyperperfusion can be prevented by minimizing intraoperative cerebral ischemia and strict postoperative blood pressure control under continuous sedation. Neurosurgery 64:447–453; discussion 453-444.  https://doi.org/10.1227/01.neu.0000339110.73385.8a CrossRefGoogle Scholar
  12. 12.
    Kobayashi E, Saeki N, Oishi H, Hirai S, Yamaura A (2000) Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J Neurosurg 93:976–980.  https://doi.org/10.3171/jns.2000.93.6.0976 CrossRefGoogle Scholar
  13. 13.
    Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y (2005) Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 36:2148–2153.  https://doi.org/10.1161/01.str.0000182256.32489.99 CrossRefGoogle Scholar
  14. 14.
    Kuroda S, Kawabori M, Hirata K, Shiga T, Kashiwazaki D, Houkin K, Tamaki N (2014) Clinical significance of STA-MCA double anastomosis for hemodynamic compromise in post-JET/COSS era. Acta Neurochir 156:77–83.  https://doi.org/10.1007/s00701-013-1961-0 CrossRefGoogle Scholar
  15. 15.
    Liu X, Zhang D, Shuo W, Zhao Y, Wang R, Zhao J (2013) Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease. J Neurol Neurosurg Psychiatry 84:258–265.  https://doi.org/10.1136/jnnp-2012-302236 CrossRefGoogle Scholar
  16. 16.
    Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, Nakagawara J, Takahashi JC (2014) Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya trial. Stroke 45:1415–1421.  https://doi.org/10.1161/strokeaha.113.004386 CrossRefGoogle Scholar
  17. 17.
    Morioka M, Hamada J, Kawano T, Todaka T, Yano S, Kai Y, Ushio Y (2003) Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients. Stroke 34:90–95CrossRefGoogle Scholar
  18. 18.
    Morioka M, Hamada J, Todaka T, Yano S, Kai Y, Ushio Y (2003) High-risk age for rebleeding in patients with hemorrhagic moyamoya disease: long-term follow-up study. Neurosurgery 52:1049–1054 discussion 1054-1045Google Scholar
  19. 19.
    Morisawa H, Kawamata T, Kawashima A, Hayashi M, Yamaguchi K, Yoneyama T, Okada Y (2013) Hemodynamics and changes after STA-MCA anastomosis in moyamoya disease and atherosclerotic cerebrovascular disease measured by micro-Doppler ultrasonography. Neurosurg Rev 36:411–419.  https://doi.org/10.1007/s10143-012-0441-y CrossRefGoogle Scholar
  20. 20.
    Ni W, Xu F, Xu B, Liao Y, Gu Y, Song D (2012) Disappearance of aneurysms associated with moyamoya disease after STA-MCA anastomosis with encephaloduro myosynangiosis. J Clin Neurosci 19:485–487.  https://doi.org/10.1016/j.jocn.2011.05.036 CrossRefGoogle Scholar
  21. 21.
    Ohue S, Kumon Y, Kohno K, Watanabe H, Iwata S, Ohnishi T (2008) Postoperative temporary neurological deficits in adults with moyamoya disease. Surg Neurol 69:281–286; discussion 286-287.  https://doi.org/10.1016/j.surneu.2007.01.047 CrossRefGoogle Scholar
  22. 22.
    Okada Y, Shima T, Nishida M, Yamane K, Yamada T, Yamanaka C (1998) Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya disease: cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. Stroke 29:625–630CrossRefGoogle Scholar
  23. 23.
    Okada Y, Shima T, Yamane K, Yamanaka C, Kagawa R (1999) Cylindrical or T-shaped silicone rubber stents for microanastomosis—technical note. Neurol Med Chir 39:55–57 discussion 57-58CrossRefGoogle Scholar
  24. 24.
    Research (2012) Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir 52:245–266CrossRefGoogle Scholar
  25. 25.
    Su IC, Yang CC, Wang WH, Lee JE, Tu YK, Wang KC (2008) Acute cerebral ischemia following intraventricular hemorrhage in moyamoya disease: early perfusion computed tomography findings. J Neurosurg 109:1049–1051.  https://doi.org/10.3171/jns.2008.109.12.1049 CrossRefGoogle Scholar
  26. 26.
    Suzuki J, Kodama N (1983) Moyamoya disease—a review. Stroke 14:104–109CrossRefGoogle Scholar
  27. 27.
    Takahashi JC, Funaki T, Houkin K, Inoue T, Ogasawara K, Nakagawara J, Kuroda S, Yamada K, Miyamoto S (2016) Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan Adult Moyamoya trial. Stroke 47:37–43.  https://doi.org/10.1161/strokeaha.115.010819 CrossRefGoogle Scholar
  28. 28.
    Uchino H, Nakayama N, Kazumata K, Kuroda S, Houkin K (2016) Edaravone reduces hyperperfusion-related neurological deficits in adult moyamoya disease: historical control study. Stroke 47:1930–1932.  https://doi.org/10.1161/strokeaha.116.013304 CrossRefGoogle Scholar
  29. 29.
    Wrede KH, Johst S, Dammann P, Ozkan N, Monninghoff C, Kraemer M, Maderwald S, Ladd ME, Sure U, Umutlu L, Schlamann M (2014) Improved cerebral time-of-flight magnetic resonance angiography at 7 Tesla—feasibility study and preliminary results using optimized venous saturation pulses. PLoS One 9:e106697.  https://doi.org/10.1371/journal.pone.0106697 CrossRefGoogle Scholar
  30. 30.
    Yamaguchi K, Kawamata T, Kawashima A, Hori T, Okada Y (2010) Incidence and predictive factors of cerebral hyperperfusion after extracranial-intracranial bypass for occlusive cerebrovascular diseases. Neurosurgery 67:1548–1554; discussion 1554.  https://doi.org/10.1227/NEU.0b013e3181f8c554 CrossRefGoogle Scholar
  31. 31.
    Yoshida Y, Yoshimoto T, Shirane R, Sakurai Y (1999) Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: an extensive follow-up study. Stroke 30:2272–2276CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019
corrected publication 2019

Authors and Affiliations

  • Taichi Ishiguro
    • 1
  • Yoshikazu Okada
    • 2
  • Tatsuya Ishikawa
    • 1
  • Koji Yamaguchi
    • 1
  • Akitsugu Kawashima
    • 3
  • Takakazu Kawamata
    • 1
    Email author
  1. 1.Department of NeurosurgeryTokyo Women’s Medical UniversityTokyoJapan
  2. 2.Department of NeurosurgerySt. Luke’s International HospitalTokyoJapan
  3. 3.Department of NeurosurgeryTokyo Women’s Medical University Yachiyo Medical CenterChibaJapan

Personalised recommendations